Sensei biotherapeutics to participate in canaccord genuity's 43rd annual growth conference

Boston, aug. 02, 2023 (globe newswire) -- sensei biotherapeutics, inc. (nasdaq: snse), a clinical stage immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, today announced that company management will participate in a fireside chat at canaccord genuity's 43rd annual growth conference, being held in boston, ma, on wednesday, august 9, 2023 at 9:30 a.m. et.
SNSE Ratings Summary
SNSE Quant Ranking